FLGT
Fulgent Genetics Inc
Price:  
19.88 
USD
Volume:  
195,012.00
United States | Health Care Providers & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

FLGT WACC - Weighted Average Cost of Capital

The WACC of Fulgent Genetics Inc (FLGT) is 6.9%.

The Cost of Equity of Fulgent Genetics Inc (FLGT) is 6.95%.
The Cost of Debt of Fulgent Genetics Inc (FLGT) is 5.50%.

Range Selected
Cost of equity 5.80% - 8.10% 6.95%
Tax rate 20.00% - 23.80% 21.90%
Cost of debt 4.00% - 7.00% 5.50%
WACC 5.8% - 8.1% 6.9%
WACC

FLGT WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.43 0.57
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.80% 8.10%
Tax rate 20.00% 23.80%
Debt/Equity ratio 0.01 0.01
Cost of debt 4.00% 7.00%
After-tax WACC 5.8% 8.1%
Selected WACC 6.9%

FLGT's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for FLGT:

cost_of_equity (6.95%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.43) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.